Human medicines European public assessment report (EPAR): Ultomiris, ravulizumab, Hemoglobinuria, Paroxysmal, Date of authorisation: 02/07/2019, Revision: 13, Status: Authorised
Quarterly system demo - Q3 2023, Online, 09:00 - 13:00 Amsterdam time (CEST), from 21/09/2023 to 21/09/2023
How to find us
Orientation guide for patient representatives and healthcare professionals - EMA building
Orientation guide for delegates - EMA building
Human medicines European public assessment report (EPAR): Abrysvo, Respiratory syncytial virus vaccine (bivalent, recombinant), Respiratory Syncytial Virus Infections, Date of authorisation: 23/08/2023, Status: Authorised
Human medicines European public assessment report (EPAR): Myfenax, mycophenolate mofetil, Graft Rejection, Date of authorisation: 21/02/2008, Revision: 27, Status: Authorised
Human medicines European public assessment report (EPAR): Brimica Genuair, aclidinium,formoterol fumarate dihydrate, Pulmonary Disease, Chronic Obstructive, Date of authorisation: 19/11/2014, Revision: 14, Status: Authorised
MedDRA Important medical event terms list - version 26.1
Vaccine Monitoring Platform